The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000589381p
Ethics application status
Help: Ethics application status
Not yet submitted
Date submitted
Help: Date submitted
9/04/2026
Date registered
Help: Date registered
11/05/2026
Date last updated
Help: Date last updated
11/05/2026
Date data sharing statement initially provided
Help: Data sharing statement date
11/05/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Springfield Healthy Hearts Pop-Up Screening: Feasibility and Risk Identification
Scientific title
Springfield Healthy Hearts Pop-Up Screening: a pragmatic community-based single-arm pilot study of feasibility, acceptability, and cardiometabolic risk identification in adults attending pop-up Heart Health Check screening in Springfield
Additional trial identifiers [1] 316995 0
Nil known
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
prediabetes 341468 0
hypertenion 341469 0
Obesity 341472 0
Condition category
Condition code
Cardiovascular 337555 337555 0 0
Hypertension
Diet and Nutrition 337556 337556 0 0
Obesity
Metabolic and Endocrine 337557 337557 0 0
Diabetes

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Adults from the Springfield community will undergo a single pop-up “Heart Health Check” screening visit involving a brief questionnaire and cardiometabolic screening assessments delivered by UQ researchers, including point-of-care HbA1c, blood pressure, anthropometry, and liver health assessment using FibroScan. The screening visit will take ~15min to complete. Screening findings will be communicated to participants as screening results only, together with a printed results summary and brief verbal explanation, with recommendation to seek follow-up medical review where indicated.

to determine feasibility of the screening process the following outcomes will be used: count of number eligible/ineligible, number consenting, number completing screening, missing data for each measure, screening duration, whether printed results were taken by participant at the end of screening

Participants will also be invited to complete a brief online follow-up questionnaire approximately 2 weeks after screening to assess self-initiated health-related actions, perceived usefulness of the screening, and barriers to action.
Intervention code [1] 333861 0
Early detection / Screening
Description of the comparator or control
No control group
Control group
Uncontrolled

Outcomes
Primary outcome [1] 345038 0
Participant uptake
Timepoint [1] 345038 0
At the pop-up screening visit, summarised across the recruitment period.
Primary outcome [2] 345039 0
Screening throughput
Timepoint [2] 345039 0
Across pop-up screening sessions during the recruitment period, summarised at the end of recruitment.
Primary outcome [3] 345040 0
Satisfaction with the screening experience
Timepoint [3] 345040 0
Approximately 2 weeks after the screening visit.
Secondary outcome [1] 460246 0
Glycaemic risk identification
Timepoint [1] 460246 0
At the pop-up screening visit.
Secondary outcome [2] 460247 0
Blood pressure risk identification
Timepoint [2] 460247 0
At the pop-up screening visit.
Secondary outcome [3] 460248 0
Body mass index risk identification
Timepoint [3] 460248 0
At the pop-up screening visit.
Secondary outcome [4] 460249 0
Liver health risk identification
Timepoint [4] 460249 0
At the pop-up screening visit.
Secondary outcome [5] 460250 0
Self-reported cardiometabolic conditions and behavioural risk factors
Timepoint [5] 460250 0
At the pop-up screening visit.
Secondary outcome [6] 460251 0
Any self-initiated health-related action
Timepoint [6] 460251 0
Approximately 2 weeks after the screening visit.
Secondary outcome [7] 460253 0
Perceived barriers to taking action
Timepoint [7] 460253 0
Approximately 2 weeks after the screening visit.
Secondary outcome [8] 460833 0
Waist circumference risk identification
Timepoint [8] 460833 0
At the pop-up screening visit.

Eligibility
Key inclusion criteria
Potential participants will be eligible if they meet all of the following criteria:
• Aged 18 years or older.
• Attending a Springfield pop-up “Heart Health Check” screening session.
• Able to provide informed consent voluntarily.
• Able to understand written and spoken English sufficiently to complete the consent process and study procedures.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
Yes
Key exclusion criteria
Potential participants will not be eligible if they meet any of the following criteria:
• Appear acutely unwell (for example; naseau, vomiting, headaches/migraines etc) distressed, or otherwise unsuitable for participation at the time of screening, such that participation would be inappropriate or immediate clinical care would take priority.
• Have previously participated in the study.
• Self-reported current pregnancy at the time of screening

Study design
Purpose of the study
Diagnosis
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
QLD
Recruitment postcode(s) [1] 45711 0
4300 - Springfield

Funding & Sponsors
Funding source category [1] 321592 0
University
Name [1] 321592 0
University of Queensland
Country [1] 321592 0
Australia
Primary sponsor type
University
Name
University of Queensland
Address
Country
Australia
Secondary sponsor category [1] 324397 0
None
Name [1] 324397 0
Address [1] 324397 0
Country [1] 324397 0

Ethics approval
Ethics application status
Not yet submitted
Ethics committee name [1] 320118 0
University of Queensland
Ethics committee address [1] 320118 0
Ethics committee country [1] 320118 0
Australia
Date submitted for ethics approval [1] 320118 0
08/06/2026
Approval date [1] 320118 0
Ethics approval number [1] 320118 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 149494 0
Dr Callum Baker
Address 149494 0
Community Centre For Health and Wellbeing Level 7, 145 Sinnathamby Blvd, Springfield Central QLD 4300
Country 149494 0
Australia
Phone 149494 0
+61 7 3443 8787
Fax 149494 0
Email 149494 0
Contact person for public queries
Name 149495 0
Callum Baker
Address 149495 0
Community Centre For Health and Wellbeing Level 7, 145 Sinnathamby Blvd, Springfield Central QLD 4300
Country 149495 0
Australia
Phone 149495 0
+61 7 3443 8787
Fax 149495 0
Email 149495 0
Contact person for scientific queries
Name 149496 0
Callum Baker
Address 149496 0
Community Centre For Health and Wellbeing Level 7, 145 Sinnathamby Blvd, Springfield Central QLD 4300
Country 149496 0
Australia
Phone 149496 0
+61 7 3443 8787
Fax 149496 0
Email 149496 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Researchers
Conditions for requesting access:
• Yes, conditions apply:
• Requires review on a case-by-case basis by the trial custodian, sponsor or data sharing committee
• Requires a scientifically sound proposal or protocol
• Requires approval by an ethics committee
• Requires a data sharing agreement between data requester and trial custodian or sponsor
What individual participant data might be shared?
• All de-identified individual participant data
What types of analyses could be done with individual participant data?
• Any type of analysis (i.e. no restrictions on data re-use)
When can requests for individual participant data be made (start and end dates)?
From:
At the end of the study
To:
No end date
Where can requests to access individual participant data be made, or data be obtained directly?
• Email of trial custodian, sponsor or committee: [email protected]

Are there extra considerations when requesting access to individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.